子宫内膜癌患者的营养治疗专家共识

2020-12-30 中国抗癌协会肿瘤营养与支持治疗专业委员会 肿瘤代谢与营养电子杂志.2020.7(4):4415-417.

子宫内膜癌占女性生殖系统恶性肿瘤的20%~30%,2008年后子宫内膜癌已成为发病率最高的女性生殖道恶性肿瘤,2012年为女性恶性肿瘤的第5位。与消化道恶性肿瘤不同,子宫内膜癌发生恶液质的概率较低,相

中文标题:

子宫内膜癌患者的营养治疗专家共识

发布日期:

2020-12-30

简要介绍:

子宫内膜癌占女性生殖系统恶性肿瘤的20%~30%,2008年后子宫内膜癌已成为发病率最高的女性生殖道恶性肿瘤,2012年为女性恶性肿瘤的第5位。与消化道恶性肿瘤不同,子宫内膜癌发生恶液质的概率较低,相反,肥胖或超重患者比例较高,约68%的早期子宫内膜癌患者伴有肥胖。肥胖的子宫内膜癌患者易合并代谢性疾病增加死亡风险;肥胖的子宫内膜癌患者手术相关并发症发生率更高;肥胖的子宫内膜癌患者的化疗药物代谢异常影响疗效。因此,子宫内膜癌患者的个体化营养评估与营养干预应引起重视。

相关资料下载:
[AttachmentFileName(sort=1, fileName=子宫内膜癌患者的营养治疗专家共识_蔡红兵.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e07681c0020a6163, title=子宫内膜癌患者的营养治疗专家共识, enTitle=, guiderFrom=肿瘤代谢与营养电子杂志.2020.7(4):4415-417., authorId=0, author=, summary=子宫内膜癌占女性生殖系统恶性肿瘤的20%~30%,2008年后子宫内膜癌已成为发病率最高的女性生殖道恶性肿瘤,2012年为女性恶性肿瘤的第5位。与消化道恶性肿瘤不同,子宫内膜癌发生恶液质的概率较低,相, cover=https://img.medsci.cn/2021130/1611940334340_2020535.jpg, journalId=0, articlesId=null, associationId=1418, associationName=中国抗癌协会肿瘤营养与支持治疗专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Wed Dec 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>子宫内膜癌占女性生殖系统恶性肿瘤的20%~30%,2008年后子宫内膜癌已成为发病率最高的女性生殖道恶性肿瘤,2012年为女性恶性肿瘤的第5位。与消化道恶性肿瘤不同,子宫内膜癌发生恶液质的概率较低,相反,肥胖或超重患者比例较高,约68%的早期子宫内膜癌患者伴有肥胖。肥胖的子宫内膜癌患者易合并代谢性疾病增加死亡风险;肥胖的子宫内膜癌患者手术相关并发症发生率更高;肥胖的子宫内膜癌患者的化疗药物代谢异常影响疗效。因此,子宫内膜癌患者的个体化营养评估与营养干预应引起重视。</p>, tagList=[TagDto(tagId=850, tagName=子宫内膜癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=850, guiderKeyword=子宫内膜癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4597, appHits=238, showAppHits=0, pcHits=628, showPcHits=4359, likes=1, shares=18, comments=12, approvalStatus=1, publishedTime=Sat Jan 30 01:46:59 CST 2021, publishedTimeString=2020-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 30 01:12:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:45:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=子宫内膜癌患者的营养治疗专家共识_蔡红兵.pdf)])
子宫内膜癌患者的营养治疗专家共识_蔡红兵.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065824, encodeId=6b131065824c2, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Mon Nov 01 15:50:58 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060351, encodeId=e5e7106035195, content=很有帮助!马上可以用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:36:43 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965525, encodeId=f0939655252b, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Fri May 14 13:05:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954467, encodeId=11fa95446e3b, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:13 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954591, encodeId=9c56954591bd, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:49:41 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-11-01 ms6980619036574494

    很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065824, encodeId=6b131065824c2, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Mon Nov 01 15:50:58 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060351, encodeId=e5e7106035195, content=很有帮助!马上可以用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:36:43 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965525, encodeId=f0939655252b, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Fri May 14 13:05:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954467, encodeId=11fa95446e3b, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:13 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954591, encodeId=9c56954591bd, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:49:41 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-10-14 ms7000000805881231

    很有帮助!马上可以用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1065824, encodeId=6b131065824c2, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Mon Nov 01 15:50:58 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060351, encodeId=e5e7106035195, content=很有帮助!马上可以用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:36:43 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965525, encodeId=f0939655252b, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Fri May 14 13:05:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954467, encodeId=11fa95446e3b, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:13 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954591, encodeId=9c56954591bd, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:49:41 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-05-14 ms6000001608459305

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1065824, encodeId=6b131065824c2, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Mon Nov 01 15:50:58 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060351, encodeId=e5e7106035195, content=很有帮助!马上可以用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:36:43 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965525, encodeId=f0939655252b, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Fri May 14 13:05:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954467, encodeId=11fa95446e3b, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:13 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954591, encodeId=9c56954591bd, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:49:41 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1065824, encodeId=6b131065824c2, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b905522600, createdName=ms6980619036574494, createdTime=Mon Nov 01 15:50:58 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060351, encodeId=e5e7106035195, content=很有帮助!马上可以用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:36:43 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965525, encodeId=f0939655252b, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43d25501695, createdName=ms6000001608459305, createdTime=Fri May 14 13:05:07 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954467, encodeId=11fa95446e3b, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:13 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954591, encodeId=9c56954591bd, content=资料好好,但无法分享,遗憾!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 13:49:41 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    资料好好,但无法分享,遗憾!

    0

拓展阅读

2015 ASCO/ASRO:子宫内膜癌术后放射治疗循证指南

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2016-05-30

2015 ESMO/ESGO/ESTRO共识会议:子宫内膜癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2015-12-02

2015 ACOG/SGO临床指南(NO.149):子宫内膜癌

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2015-04-01

子宫内膜癌筛查和早期诊断专家共识(草案)

中国肿瘤科相关专家小组(统称) · 2017-10-30

2018 ESUR指南:子宫内膜癌MRI分期(更新)

欧洲泌尿生殖放射学会(ESUR,European Society of Urogenital Radiology) · 2018-07-11